Program  
Program at a Glance
Scientific Program
New for SICEM 2018
Invited Speakers
Official Program
   Scientific Program


::: SICEM 2018 :::

Day 1 - 4 Day 1, April 19(Thu) Day 2, April 20(Fri) Day 3, April 21(Sat) Day 4, April 22(Sun)

(K): Korean Session / (T): Simultaneous interpretation will be provided


    
[Clinical Ultrasound Hands-on #2 / 임상초음파 실습 #2] : Thyroid+Carotid / 두경부초음파(갑상선+경동맥)

*Only for Korean participants who pre-registered
*사전신청한 국내 참가자에 한함

Date & Time : April 21, 09:00-10:00   Venue : Art Hall
Speakers
Clinical Trainer/ 실습자
Soo-Kyung Kim (CHA University, Korea)
Clinical Trainer/ 실습자
Jongho Kim (Severance Hospital, Korea)
Clinical Trainer/ 실습자
Taewoong Noh (Yonsei HPIM, Korea)
Clinical Trainer/ 실습자
Chan Joo Lee (Severance Hospital, Korea)


  
[Clinical Update: Diabetes (K)]] : Recent Advances in Management of Diabetes - Beyond A1c
In the era of the Fourth Industrial Revolution, advanced technologies have brought about remarkable progress in the field of diabetes management and they will provide more precise and convenient blood glucose control to people with diabetes. This session will discuss new technologies of glucose monitoring and treatment. Prof. Mee-Kyoung Kim of the Catholic University of Korea will introduce new serologic markers to replace HbA1c. Prof. Jun Sung Moon of Yeungnam University will introduce the latest blood glucose devices that have removed the inconvenience of existing glucometer. Finally, Prof. Sang Youl RHee of Kyunghee University will discuss the present and future prospects of artificial pancreas, an ideal blood glucose control model.
Date & Time : April 19, 17:00-18:30   Venue : Vista 2
Chair
Jae-Myung Yu (Hallym University Kangnam Sacred Heart Hospital, Korea)
Seok Won Park (CHA University, Korea)
Speakers
New Serologic Markers of Glucose Monitoring
Mee Kyoung Kim (The Catholic University of Korea, Korea)
Cutting Edge Devices in Glucose Monitoring
Jun Sung Moon (Yeungnam University College of Medicine, Korea)
Artificial Pancreas
Sang Youl Rhee (Kyung Hee University School of Medicine, Korea)


  
[Worldwide Initiative for Diabetes Education for Health Care Professionals] : International Summit: Improving Outcomes in the Management of Type 2 Diabetes
Date & Time : April 19, 17:00-18:30   Venue : Vista 3
Chair
Philip Home (Newcastle University, UK)
Dongsun Kim (Hanyang University Seoul Hospital, Korea)
Speakers
The Evolving Pathophysiology of Type 2 Diabetes
Kun-Ho Yoon (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
Hypoglycemia: The Impact on Patient Function and Outcomes
Brian Frier (University of Edinburgh, UK)
The Latest Evidence for Decreased CV Risk with New Therapies for Diabetes
André J Scheen (University of Liege Chu Sart Tilman, Belgium)


  
[Special-interest Group: Adrenal] : New Diagnostic Technology in the Field of Adrenal Disease
This session will introduce new diagnostic technology that has been recently studied in the field of adrenal diseases. Professor Jung Hee Kim (Seoul National University College of Medicine, South Korea) will talk about the usefulness of steroid profiling that is thought to be a promising biomarker in Cushing’s syndrome. Professor Yuki Sugiura (Keio University, Japan) will introduce how to identify aldosterone on adrenal frozen sections using mass spectrometry. Professor Mitsuhide Naruse (Kyoto Medical Center, Japan) will announce new functional imagings that can help diagnose primary aldosteronism by showing high specificity for CYP11B enzymes compared to the conventional adrenocortical scintigraphy.
Date & Time : April 19, 17:00-18:30   Venue : Calla
Chair
Choon-Hee Chung (Yonsei University Wonju College of Medicine, Korea)
Sang Wan Kim (Seoul National University College of Medicine, Korea)
Speakers
Steroid Profiling as a Biomarker in Cushing's Syndrome
Jung Hee Kim (Seoul National University College of Medicine, Korea)
Mass Spectrometry-based Visualization of Aldosterone on Adrenal Frozen Sections
Yuki Sugiura (Keio University, School of medicine, Japan)
Recent Developments of Functional Imaging in the Diagnosis of Primary Aldosteronism
Mitsuhide Naruse (National Hospital Organization Kyoto Medical Center, Japan)


[Breakfast Symposium] : I
Date & Time : April 20, 07:30-08:30   Venue : Vista 1
Chair
Sang-Jin Kim (Soon Chun Hyang University Hospital, Cheonan, Korea)
Speakers
Translating CV Benefits of SGLT-2 inhibitor into Real World Evidence
Enrique Caballero (Harvard Medical School, USA)


  
[Clinical Update:Neuroendocrinology (K)(T)] : Treat or not?
Date & Time : April 20, 09:30-11:00   Venue : Calla
Chair
Sung Woon Kim (Kyung Hee University School of Medicine, Korea)
Byoung-Joon Kim (Gachon University Gil Medical Center, Korea)
Speakers
Menopause and HRT: Convergence of Old and New Evidence with Endocrine Aspect
Hoon Kim (Seoul National University College of Medicine, Korea)
Growth Hormone Replacement Therapy in Adults: Still Optional or Mandatory?
Yoon-Sok Chung (Ajou University School of Medicine, Korea)
Treatment of Prolactinoma : When to Start and Stop
Soon Jib Yoo (The Catholic University of Korea Bucheon St. Mary’s Hospital, Korea)


  
[Symposium: Thyroid I] : Recent Progress in the Research of Molecular Basis of Thyroid Cancer
This symposium will present recent basic research on the mechanism of thyroid carcinogenesis and treatment of thyroid cancer. Exosomes are extracellular vesicles that present in all body fluids and play important roles in a variety of biological functions and cell signal transduction. Prof. Byeong-Cheol Ahn (Kyungpook National Univ.) will present a study on the role of exosomes in thyroid cancer. Prof. Jeffrey Knauf (Memorial Sloan Kttering Cancer Center) will present a study on mouse model of anaplastic thyroid cancer. He will focus on the mechanism of acquired resistance for BRAF inhibition and provide an update on the new therapeutic approach to anaplastic thyroid cancer. Prof. Vladimir Saenko (Nagasaki Univ.) is a famous researcher in the genetic characterization of thyroid cancer. He will present a study on the genetic characteristics that are susceptible to differentiated thyroid cancer in this symposium.
Date & Time : April 20, 09:30-11:00   Venue : Vista 1
Chair
Ho-Cheol Kang (Chonnam National University Hwasun Hospital, Korea)
Tae Yong Kim (ASAN Medical Center, Korea)
Speakers
Extracellular Vesicles for Thyroid Cancers
Byeong-Cheol Ahn (Kyungpook National University, Korea)
Acquired Resistance to BRAF Inhibition in Murine Anaplastic Thyroid Cancers
Jeffrey Knauf (Memorial Sloan Kettering Cancer Center, USA)
Genetic Factors of Susceptibility to Differentiated Thyroid Cancer
Vladimir Saenko (Atomic Bomb Disease Institute, Nagasaki University, Japan)


  
[Symposium: Diabetes I] : Uncommon Types of Diabetes
Diabetes can be classified into type 1 diabetes, type 2 diabetes, and gestational diabetes mellitus. In addition, there are several specific types of diabetes due to other causes including monogenic diabetes syndromes, diseases of the exocrine pancreas, and drug- or chemical-induced diabetes. However, in some clinical circumstances, it is not easy to specify the type of diabetes and there are certain subtypes of type 1 or type 2 diabetes. In this session, three outstanding speakers will give us lectures about uncommon types of diabetes. Professor Soo Heon Kwak will tell us about rare genetic forms of diabetes including mitochondrial diabetes, congenital generalized lipodystrophy, and maturity onset diabetes of the young. Professor Paolo Pozzilli has been devoted for many years to finding the treatment modalities of type 1 diabetes and LADA (latent autoimmune diabetes of adults) by early diagnosis and combination of genetic, immunological and mathematical techniques. He will talk about the recent progress made in the diagnosis and treatment of LADA. Lastly, Professor Jean-françois Gautier will talk about the changes in insulin resistance and secretion in ketosis-prone type 2 diabetes with African cohort.
Date & Time : April 20, 09:30-11:00   Venue : Vista 2
Chair
Achmad Rudijanto (Brawijaya University - Saiful Anwar Hospital, Indonesia)
Moon Kyu Lee (Samsung Medical Center, Korea)
Speakers
Rare Genetic Causes of Diabetes
Soo Heon Kwak (Seoul National University Hospital, Korea)
LADA
Pozzilli Paolo (Università Campus Bio-Medico, Italy)
Ketosis Prone Diabetes
Jean-françois Gautier (University Paris 7, France)


  
[Symposium: Basic Research in Endocrinology I] : Bile Acid Signaling in Energy Metabolism
Bile acid is synthesized and secreted from the liver. It involves energy metabolism through its receptor FXR or TGR5. Bile acid signaling has been drawing further attention since anti-diabetes and anti-obesity of Fexaramine, aFXR agonist, was reported. In this session, Prof. Kristina Schoonjans will talk about the regulation of metabolism by TGR5, a membrane bound bile acid receptor. Prof. Sungsoon Fang will show the recent result on the regulation of hepatic lipid homeostasis by nuclear receptor crosstalk. Prof. Jae Man Lee will give a talk about the critical role of SHP in the regulation of nutrient sensing, basal autophagy and energy homeostasis.
Date & Time : April 20, 09:30-11:00   Venue : Vista 3
Chair
Kwan-Woo Lee (Ajou University School of Medicine, Korea)
Dae Ho Lee (Gachon University Gil Medical Center, Korea)
Speakers
TGR5 Signaling and Control of Metabolism
Kristina Schoonjans (Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland)
Nuclear Receptor Crosstalks Control Hepatic Lipid Homeostasis
Sungsoon Fang (Yonsei University College of Medicine, Korea)
The Nuclear Receptor SHP is a Critical Regulator of Nutrient Sensing, Basal Autophagy, and Energy Homeostasis
Jae Man Lee (Kyungpook National University School of Medicine, Korea)


  
[Symposium: Bone I] : Interaction between Bone and Other Organs
Date & Time : April 20, 09:30-11:00   Venue : Cosmos
Chair
Dong Won Byun (Soon Chun Hyang University Hospital, Seoul, Korea)
Deog-Yoon Kim (Kyung Hee University Hospital, Korea)
Speakers
Osteocalcin Signaling for Optimum Adaptation to Exercise
Gerard Karsenty (Columbia University, USA)
Cathepsin K Activity Controls Cardiotoxin-induced Skeletal Muscle Repair in Mice
Xianwu Cheng (Yanbian University Hospital, China)
Muramyl Dipeptide Is A Novel Inducer of Bone Formation Through Activation of Nod2 and Runx2
Seung Hyun Han (Seoul National University School of Dentistry, Korea)


  
[Plenary Lecture I] : Basic Research
Prof. Johan Auwerx and his team have been using systems approaches to map the signaling networks that govern mitochondrial function and as such regulate organismal metabolism in health, aging and disease. While he addresses basic biomedical questions, he takes advantage of his medical background to translate his research into novel preventive and therapeutic strategies for type 2 diabetes, frailty, and obesity. In this plenary session, he will show what he has done to improve the understanding of how signaling pathways control mitochondrial function and metabolism.
Date & Time : April 20, 11:30-12:10   Venue : Walkerhill Theatre
Chair
Kyoil Suh (Soon Chun Hyang University Hospital, Seoul, Korea)
Speakers
Genetic Analysis of Mitochondrial Function Metabolism and Aging
Johan Auwerx (Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland)


[Luncheon Symposium] : I
Date & Time : April 20, 12:10-13:00   Venue : Vista 1
Chair
Kang Seo Park (Eulji University School of Medicine, Korea)
Speakers
The Paradigm Changer: Simple and Easy Treatment for your T2DM Patients
Nam Hoon Kim (Korea University College of Medicine, Korea)


[Luncheon Symposium] : II
Date & Time : April 20, 12:10-13:00   Venue : Vista 2
Chair
Young-Sik Choi (Kosin University College of Medicine, Korea)
Speakers
What is The ‘Essential’ Treatment of Type 2 Diabetes?
Richard Donnelly (University of Nottingham, UK)


[Luncheon Symposium] : III
Date & Time : April 20, 12:10-13:00   Venue : Vista 3
Chair
Kyung Soo Ko (Inje University Sanggye Paik Hospital, Korea)
Speakers
Pathophysiologic Combination Therapy: Consideration targeting β-cell Function
Eun Seok Kang (Severance Hospital, Korea)


  
[Meet The Professor] : Special
Date & Time : April 20, 13:00-13:40   Venue : Calla
Speakers
How to Write a Paper; How to Read and Review a Paper
Christoph Wanner (University Hospital of Würzburg, Germany)


  
[Special Lecture] : 4th Industrial Revolution and Health Care
Date & Time : April 20, 13:00-13:40   Venue : Cosmos
Chair
Doo-Man Kim (Hallym University Sacred Heart Hospital, Korea)
Speakers
Internet of Things, Smart Communities, and Healthcare
Sokwoo Rhee (National Institute of Standards and Technology, USA)


  
[Special Session] : The World’s Most Influential Scientific Minds in Endocrinology 2017 I
The World’s Most Influential Scientific Minds in Endocrinology 2017 is the session featuring the world-renowned experts in diabetes, bone metabolism, thyroid and neuroendocrinology to review the most influential articles of 2017. Indeed, the session will help you to stay up to date with the latest trends and the most influential studies with interpretation about clinical importance, implication and limitation of studies from the experts in each field.
Date & Time : April 20, 13:00-13:50   Venue : Vista 1
Chair
Pepito E. Dela Peña (Philippine College of Physicians, Philippine Society of Endocrinology, Diabetes, and Metabolism , Philippines)
Yona Greenman (Tel Aviv-Sourasky Medical Center, Israel)
Speakers
The World’s Most Influential Scientific Minds in Endocrinology 2017: Diabetes and Obesity
Kun-Ho Yoon (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
The World’s Most Influential Scientific Minds in Endocrinology 2017: Neuroendocrine and Adrenal
Sung Woon Kim (Kyung Hee University School of Medicine, Korea)


  
[Plenary Lecture II] : Thyroid
For the last several years, our knowledge about thyroid hormone effects on fetus and mother has been dramatically increasing but many physicians are still confused about decision on the management of thyroid disease during pregnancy in real clinical practice.
Dr. Gregory A Brent, professor of the Department of Medicine, VA Greater Los Angeles Healthcare System at UCLA in Los Angeles, CA and expert in thyroid hormone basic research, will tell the audience about the evidence-based clinical decision and the management of thyroid disease during pregnancy, based on recently published management guidelines entitled “Guidelines for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum.” He participated in developing these guidelines, as a key member of American thyroid association guidelines task force and his lecture will help the audience to understand and to examine complicated patients with thyroid disease during pregnancy or the postpartum period.
Date & Time : April 20, 14:00-14:40   Venue : Walkerhill Theatre
Chair
Ka Hee Yi (SMG - SNU Boramae Medical Center, Korea)
Speakers
Management of Thyroid Disease during Pregnancy
Gregory A. Brent (UCLA, USA)


  
[Special Session: ESE-KES Joint Symposium] : Adrenal Diseases in Korea and Europe: The Future Network for Adrenal Tumors between Asia and Europe
For SICEM 2018, we organized a joint symposium with the Korean Endocrinology Society and the European Endocrinology Society. Professor Jerome Bertherat of Cochin Hospital in Paris, France and Professor Felix Beuschlein of Munich University in Germany and Professor Jung Hee Kim of Seoul National University in Korea will participate in this session on the theme of Adrenal Diseases in Korea and Europe: the Future Network for Adrenal Tumors between Asia and Europe. Prof. Jerome Bertherat and Prof. Felix Beuschlein, both ESE Executive Committee members and experts on adrenal gland will be presenting the Adrenal Cushing and Primary Aldosteronism, respectively, at ESE-KES Joint Symposium. Moreover, Prof. Jung Hee Kim is scheduled to present the optimal follow-up strategies for adrenal incidentalomas (Adrenal incidentaloma: How and When to follow-up?).
Date & Time : April 20, 15:00-16:30   Venue : Cosmos
Chair
Sei-Hyun Baik (Korea University Guro Hospital, Korea)
Soon Jib Yoo (The Catholic University of Korea Bucheon St. Mary’s Hospital, Korea)
Speakers
Adrenal Diseases in Korea and Europe: The Future Network for Adrenal Tumors between Asia and Europe Cushing
Jerome Bertherat (Paris Descartes University, France)
Adrenal diseases in Korea and Europe: The Future Network for Adrenal Tumors between Asia and Europe Primary Aldosteronism
Felix Beuschlein (University Clinic Zurich, Switzerland)
Follow-Up of Adrenal Incidentalomas, When and How?
Jung Hee Kim (Seoul National University College of Medicine, Korea)


  
[Special-interest Group: Thyroid(K)] : Bigger Data in Thyroid Research
Thyroidology is a field of medicine that was established very long ago. However, evidence for the diagnosis and treatment of thyroid disease is based not on systematic and scientific evidence but on personal experience or on small-scale evidence. During the symposium, Professor Kim Min-Hee will share his research experience of analyzing the 2013-2015 Korean National Health and Nutrition Survey, which was conducted with an additional thyroid function test. In Korea, the entire people are subscribed to the only medical insurance program. Professor Kim Tae Hyuk analyzed the association between anti-thyroid medication and birth defects using data from the Korean National Health Insurance Service and will share the experience. Professor Jeon Min Ji will announce the real world experience of tyrosine kinase inhibitor in the treatment of thyroid cancer, which was obtained through collaboration with six tertiary hospitals in Korea.
Date & Time : April 20, 15:00-16:30   Venue : Calla
Chair
Won Bae Kim (ASAN Medical Center, Korea)
Sun Wook Kim (Samsung Medical Center, Korea)
Speakers
Experience of Thyroid Research based on Korean National Health and Nutrition Examination Survey (KNHANES) Data
Min Hee Kim (The Catholic University of Korea, St. Paul’s hospital, Korea)
Experience of Study Using Health Insurance Review and Assessment Service (HIRA) Data
Tae Hyuk Kim (Samsung Medical Center, Korea)
Experience of Multi-center Study in Korea
Min Ji Jeon (ASAN Medical Center, Korea)


  
[Special-interest Group: EDC] : Impact of Endocrine Disrupting Chemicals on Obesity and Obesity Related Disease
Endocrine disrupting chemicals (EDCs) are mostly man-made, found in various materials such as pesticides, metals, additives or contaminants in food, and personal care products. EDCs have been suspected to be associated with altered reproductive function in males and females, obesity, type 2 diabetes, cardiovascular disease, hormone-sensitive cancers, thyroid disruption and neurodevelopment. Now, every clinician treating these diseases needs to be more interested in EDCs.
In SICEM 2018, there will be an interesting lectures by leading researchers of EDCs fields. Prof. Bruce Blumberg (University of California, Irvine, USA) will present his valuable recent study entitled “Prenatal Obesogen Exposure Leads to a Transgenerational Thrifty Phenotype in Mice” and Prof. Dianna Magliano (Baker Heart and Diabetes Institute, Australia) will talk about the recent update on Association between Environmental Pollutants and Diabetes. Lastly. Prof. Mi-Jung Park (Inje University. Korea) will review the mechanisms of pubertal onset and impact of endocrine disruptors on general reproductive health, especially focus on the evidence of EDC on pubertal timing in animal models and in human epidemiological studies.
Date & Time : April 20, 15:00-16:30   Venue : Grand 4
Chair
Sung-Hoon Kim (Cheil General Hospital, Korea)
Youngmi Kim Pak (Kyung Hee University School of Medicine, Korea)
Speakers
Prenatal Obesogen Exposure Leads to a Transgenerational Thrifty Phenotype in Mice
Bruce Blumberg (University of California, Irvine, USA)
Environmental Pollutants and Diabetes: An Update
Dianna Magliano (Baker Heart and Diabetes Institute, Australia)
Impact of Endocrine Disruptors on Puberty
Mi Jung Park (Inje University Sanggye Paik Hospital, Korea)


  
[Symposium: Diabetes II (Debate Session)] : What is the Ideal Antidiabetic Agent for your Diabetic Patients at High Cardiovascular Risk?
Date & Time : April 20, 15:00-16:30   Venue : Vista 2
Chair
Bong Yun Cha (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
Yong-Wook Cho (CHA Medical Center, Korea)
Speakers
GLP-1 Receptor Agonists - Now Is It Time to Change The Diabetes Treatment from Glycemic Control to Prevention of Diabetic Complications All at Once?
Jeong Hyun Park (Inje University College of Medicine, Korea)
GLP-1 Receptor Agonists - Now Is It Time to Change The Diabetes Treatment from Glycemic Control to Prevention of Diabetic Complications All at Once?
Eun-Jung Rhee (Sungkyunkwan University Kangbuk Samsung Hospital, Korea)
Why Do We Have to Choose SGLT2 Inhibitor?
Mi-Kyung Kim (Keimyung University School of Medicine, Korea)
Why Do We Have to Choose SGLT2 Inhibitor?
Soo Lim (Seoul National University Bundang Hospital, Korea)


  
[Symposium: Basic Research in Endocrinology II] : Current Topics in Cancer Metabolism
In general, cancers occur upon genetic aberrations that affect the cellular signaling pathways controlling key events such as cellular growth. In spite of the diverse origin of various cancers, most cancer cells exhibit the similar metabolic transition to support their sustained growth and the invasive potentials. Currently, many therapeutics are developed to block these metabolic adaptations to repress the cancer growth and the subsequent metastasis. In this session, Professor Kohjiro Ueki (National Center for Global Health and Medicine, Japan) will delineate the role of insulin signaling in the gut and the liver in the development of NASH-mediated cancer, and Professor Minho Shong (Chungnam National University, Korea) will focus on the dysregulated organelle quality control in thyroid cancer. Finally, Professor Young Chan Chae (Ulsan National Institute of Science and Technology, Korea) will discuss the metabolic reprogramming in cancer mitochondria and therapeutic targets.
Date & Time : April 20, 15:00-16:30   Venue : Vista 3
Chair
Myung-Shik Lee (Yonsei University College of Medicine, Korea)
Kyong Soo Park (Seoul National University Hospital , Korea)
Speakers
Role of Insulin Action in Liver and Gut for the Development of NASH-associated Cancer
Kohjiro Ueki (National Center for Global Health and Medicine, Japan)
Dysregulation of Organelle Quality Control in Thyroid Cancer
Minho Shong (Chungnam National University, Korea)
Metabolic Reprogramming in Cancer Proliferation and Survival
Young Chan Chae (Ulsan National Institute of Science and Technology, Korea)


  
[Symposium: Bone II] : Update of Osteoporosis Treatment
Recently, Denosumab has been introduced in the Korean market for osteoporosis, and interesting data from various clinical studies has been published. In addition, teriparatide, a bone-forming agent, has recently become more clinically available due to the establishment of new reimbursement criteria. In addition, many novel drugs, such as abalopartide and romosozumab, have been developed and introduced as new bone-forming agents. This session will be a session to discuss the results of interesting clinical studies of these various new drugs. A first speaker, professor Michael McClung (Osteoporosis Center/USA), will share recent updated clinical researches’ data related to denosumab. Professor Yumie Rhee (Yonsei University), who is the second speaker, will share clinical data about teriparatide. The third speaker, professor Sang Wan Kim will show promising data on novel anabolic drugs such as anti-sclerostin antibody.
Date & Time : April 20, 15:00-16:30   Venue : Vista 1
Chair
Moo-Il Kang (Seoul St. Mary’s Hospital Catholic University of Korea, Korea)
Dong Jin Chung (Chonnam National University Hospital, Korea)
Speakers
New Insight into the Efficacy of Anti-resorptive Agents: Denosumab
Michael McClung (Oregon Osteoporosis Center, USA)
Insights into Use of Anabolic Therapy for Osteoporosis
Yumie Rhee (Yonsei University College of Medicine, Korea)
Upcoming New Drugs for Osteoporosis Management
Sang Wan Kim (Seoul National University College of Medicine, Korea)


  
[Symposium:Committee of the Health Insurance(K)] : Insurance and Reimbursement Issue on Endocrine Drugs
Date & Time : April 20, 16:00-17:45   Venue : Art Hall
Chair
Tae-Sun Park (Chonbuk National University Medical School, Korea)
Chong Hwa Kim (Sejong General Hospital, Korea)
Speakers
The Change of Insurance Policy : 2018 Update 
Myung-Sub Kwak (Ministry of Health & Welfare, Korea)
Evaluation and Management of Medication Usage: 2018 HIRA Update
Sook-Hyun Lee (Health Insurance Review & Assessment Service, Korea)
Direction to Improve Insurance Benefits of Endocrine Drugs
Seung Joon Oh (Kyung Hee University School of Medicine, Korea)
Panel
Sang Kwon Oh (Health Insurance Review & Assessment Service, Korea)
Panel
Min Jeong Kwon (Inje University Busan Paik Hospital, Korea)
Panel
Jung Soo Lim (Yonsei University Wonju College of Medicine, Korea)
Panel
Seong-Su Moon (Dongguk University College of Medicine, Korea)


  
[Special Session] : Innovative Therapeutics in the Near Future
Date & Time : April 20, 16:30-18:00   Venue : Cosmos
Chair
Kyu Chang Won (Yeungnam University Medical Center, Korea)
Sin Gon Kim (Korea University Anam Hospital, Korea)
Speakers
Innovative Therapeutics in the Near Future – Bone
Michael McClung (Oregon Osteoporosis Center, USA)
Advances in the Treatment and Management of Acromegaly and Cushing’s Disease
Andrea Lauer (Novartis Oncology, Singapore)
Innovative Therapeutics in the Near Future - Obesity
Mads Tang-Christensen (Novo Nordisk, Denmark)


  
[Symposium: Neuroendocrinology] : Forthcoming Neuroendocrinology 
Date & Time : April 20, 16:30-18:00   Venue : Vista 1
Chair
Eun Jig Lee (Yonsei University College of Medicine, Korea)
Min-Seon Kim (ASAN Medical Center, Korea)
Speakers
Visualizing and Manipulating Mouse/Human Brain for Metabolism Research
Hyung Jin Choi (Seoul National University College of Medicine, Korea)
Parameters Associated with Dopamine Agonist Responsiveness
Cheol Ryong Ku (Yonsei University College of Medicine, Korea)
Present and Future Perspectives for Medical Therapy of Nonfunctioning Pituitary Adenomas
Yona Greenman (Tel Aviv-Sourasky Medical Center, Israel)


  
[Symposium: Adrenal] : Controversy in the Adrenal Diseases
Date & Time : April 20, 16:30-18:00   Venue : Vista 2
Chair
Jerome Bertherat (Paris Descartes University, France)
Hyun Shik Son (The Catholic University of Korea Uijeongbu St. Mary’s Hospital, Korea)
Speakers
Clinical Significance of Co-secretion of Glucocorticoid in Primary Aldosteronism
Mitsuhide Naruse (National Hospital Organization Kyoto Medical Center, Japan)
Radiofrequency Ablation for Adrenal Mass: Alternative for Surgery?
Byung Kwan Park (Samsung Medical Center, Korea)
Preoperative Alpha Blockade for Pheochromocytoma and Paraganglioma: Is It Necessary?
Felix Beuschlein (University Clinic Zurich, Switzerland)


  
[Symposium: Reproductive] : PCOS across the Races: Phenotypes and Diagnostic Issues
Polycystic ovary syndrome (PCOS) is known to affect 5 to 15 % of women of reproductive age and characterized by hyperandrogenism and ovulatory dysfunction. However, there are some difficulties in the diagnosis and treatment of PCOS because of different diagnostic criteria, lack of consensus on the phenotype definitions and substantial ethnic variation in clinical presentations. In this symposium, Dr. Jinju Kim and Dr. Duarte Pignatelli will talk about the phenotypic characteristics in Asian and other races. And Dr. Hyejin Lee will discuss the issues in diagnosing the PCOS across the races.
Date & Time : April 20, 16:30-18:00   Venue : Vista 3
Chair
Bulent O Yildiz (Hacettepe University School of Medicine, Turkey)
Yeon Ah Sung (Ewha Womans University School of Medicine, Korea)
Speakers
The Phenotypic Characteristic of Asian PCOS
Jin-Ju Kim (Seoul National University Hospital, Korea)
The Characteristics of PCOS in Other Races
Duarte Pignatelli (Faculty of Medicine of Porto, Portugal)
The Issues in Diagnosing PCOS Across the Races
Hye Jin Lee (Ewha Womans University School of Medicine, Korea)


[Breakfast Symposium] : II
Date & Time : April 21, 07:30-08:30   Venue : Vista 1
Chair
Ho-Sang Shon (Daegu Catholic University College of Medicine, Korea)
Speakers
Can Antidiabetic Drugs Prevent Cardiovascular and Chronic Kidney Disease Progression?
Christoph Wanner (University Hospital of Würzburg, Germany)


[Breakfast Symposium] : III
Date & Time : April 21, 07:30-08:30   Venue : Vista 2
Chair
Ie Byung Park (Gachon University Gil Medical Center, Korea)
Speakers
Real-world Evidence for Gemigliptin's Clinical Effectiveness and Safety
So-Hun Kim (Inha University Hospital, Korea)


  
[Special Session: AFES-ESROC-KES Joint Symposium] : Post-menopausal Osteoporosis Prevention and Treatment: Current Status and Future Perspectives
AFES (ASEAN Federation of Endocrine Societies Congress) is an institution that represents the experts in the endocrinology of the Association of Southeast Asian Nations including Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam. For SICEM 2018, the Korean Endocrinology Society organized a joint session with the AFES and the ESROC (Endocrine Society of the Republic of China). This session will consist of one lecture and 9 general topics on the theme of Post-menopausal Osteoporosis Prevention and Treatment: Current Status and Future Perspectives. The special lecture will be presented by Prof. Tuan Nguyen from Australia, while Professor Monica Therese Cating-Cabral from the Philippines; Prof. Roy Panusunan Sibarani from Indonesia; Prof. Unnop Jaisramrarn from Thailand; Prof. Lan Ho-Pham from Vietnam; Prof. Vivien Lim from Singapore; Prof. Wei-Yih Chiu from Taiwan; Prof. Chii Min Hwu from Taiwan; Prof Dong Ock Lee from National Cancer Center and Yoon-Sok Chung from Ajou University (Korea) will announce the status of postmenopausal osteoporosis in each country.
Date & Time : April 21, 08:30-11:00   Venue : Vista 1
Chair
Vivien Lim (Gleneagles Hospital, Singapore)
Chii-Min Hwu (Taipei Veterans General Hospital, Taiwan)
Yoon-Sok Chung (Ajou University School of Medicine, Korea)
Speakers
Personalized Fracture Risk Assessment: State-of-the-Art and Room for Improvement
Tuan Nguyen (Garvan Institute of Medical Research, Australia)
Post-Menopausal Osteoporosis Prevention and Treatment: Current Status and Future Perspectives in the Philippines
Monica Therese Cating-Cabral (St. Luke’s Medical Center Global City, Philippines)
The Seen and Unseen Risk Factors for Osteoporosis: Indonesia Experience
Roy Panusunan Sibarani (Endocrine Centre, Indonesia)
Bone Health in the Land of Smiles
Unnop Jaisamrarn (Chulalongkorn University, Thailand)
Osteoporosis and Diabetes
Lan Ho-Pham (Pham Ngoc Thach University of Medicine, Vietnam)
Uncommon Forms of Osteoporosis
Wei-Yih Chiu (Taiwan University Hospital, Taiwan)
Epidemiology and Current Issues about Osteoporosis in Korea
Dong Ock Lee (National Cancer Center, Korea)


  
[Special Session] : 4th Industrial Revolution and Appropriate Technology for Health Care
Date & Time : April 21, 09:30-10:30   Venue : Calla
Chair
Kun-Ho Yoon (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
Yu-Bae Ahn (The Catholic University of Korea St. Vincent's Hospital, Korea)
Speakers
Fourth Industrial Revolution and Health Care Technology: Hypes and Hopes
Tae-Hwan Lim (ASAN Medical Center, Korea)
Application of Technologies in Endocrinology Department in 4th Industrial Revolution
Jae-Hyoung Cho (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
4th Industrial Revolution and Endocrine care – Focused on Appropriate Technology
Sang Youl Rhee (Kyung Hee University School of Medicine, Korea)


  
[Special Session: SICEM-EnM in Asia​] : Seeking for the United Collaboration among Asian Endocrinologic Associations through Publication
This session aims to promote EnM’s own growth and the cooperative development of other Asian endocrine journals. We have invited the Editors of excellent Asian endocrine journals to share the current status and future directions for the development of their own journals, and what kind of efforts they are making to achieve their goals. Through this opportunity to share with one another, we believe that all journals, including EnM, will be able to take the current status of their journals one step higher. In this session, Prof. Elizabeth Paz-Pacheco from the Philippines, the Editor-in-Chief of JAFES, the official journal of ASEAN Federation of Endocrine Societies, Prof. Jun-Sung Moon, the vice-secretary of Diabetes and Metabolism Journal recently listed in SCIE, Prof. Chii Min Hwu, the Editor-in-Chief of Formosan Journal of Endocrinology and Metabolism, the official journal of the Endocrine Society of the Republic of China, and Prof. Won-Young Lee, the Editor-in-Chief of EnM will introduce each journal’s current status and future scopes, and their efforts to achieve the scopes. Anyone who is interested in the promotion of Asian endocrine journals is welcome to participate in our session and share ideas on the future of our endocrine journals.
Date & Time : April 21, 09:30-11:00   Venue : Grand 4
Chair
Elizabeth Paz-Pacheco (University of the Philippines –Philippine General Hospital, Philippines)
Won-Young Lee (Sungkyunkwan University Kangbuk Samsung Hospital , Korea)
Speakers
Reviving the Journal of the ASEAN Federation of Endocrine Societies(JAFES):6-year Experience of a Regional Journal for Endocrinology
Elizabeth Paz-Pacheco (University of the Philippines –Philippine General Hospital, Philippines)
Collaboration and Harmonization to Overcome Metabolic Disorders -Diabetes & Metabolism Journal
Jun Sung Moon (Yeungnam University College of Medicine, Korea)
Past, Present and Future of Endocrinology and Metabolism
Won-Young Lee (Sungkyunkwan University Kangbuk Samsung Hospital , Korea)
Formosan Journal of Endocrinology and Metabolism: Past, Present, and Future
Chii-Min Hwu (Taipei Veterans General Hospital, Taiwan)


  
[Symposium: Thyroid II] : Update of Immunology in Thyroid Research
Thyroid disease is closely related to the immune system. Recently, the therapeutic strategies for modulating the immune system have been developed in various diseases. This symposium discusses the latest immunological issues related to thyroid disease. Professor Jena French of the University of Colorado Denver will lecture on Immune Profiling in the Development of Combination Therapies for Advanced Thyroid Cancers, and Professor Kim Tae Hyuk of Sungkyunkwan University School of Medicine plans to introduce the latest research results on irAE of immunotherapy. Professor Jin Sook Yoon of Yonsei University will discuss the latest knowledge of thyroid-associated orbitopathy.
Date & Time : April 21, 09:30-11:00   Venue : Vista 2
Chair
Jae Hoon Chung (Samsung Medical Center, Korea)
Young-Joo Park (Seoul National University Hospital, Korea)
Speakers
Immune Profiling in the Development of Combination Therapies for Advanced Thyroid Cancers
Jena French (University of Colorado Denver, Anschutz Medical Campus, USA)
Endocrine Immune-Related Adverse Events (irAEs)
Tae Hyuk Kim (Samsung Medical Center, Korea)
Recent Advances in Understanding Graves' Orbitopathy
Jin Sook Yoon (Yonsei University College of Medicine, Korea)


  
[Symposium: Basic Research in Endocrinology III] : Receptor Signaling in Adipocytes
Adipose tissue, defined as white adipose tissue (WAT) and brown adipose tissue (BAT), is now considered an endocrine organ, acting as central players in the development of obesity and associated metabolic syndromes. WAT primarily stores energy whereas BAT generates body heat. Recent studies have identified the existence of inducible brown-like (beige) adipocytes in WAT and suggest that the detailed understanding of the signaling in adipose tissue plasticity and their interaction with other organs is a prerequisite to develop new therapeutic approaches to the treatment of metabolic disease. This symposium will focus on recent findings on receptor signaling in adipose tissues. Professor Sheila Collins will deliver the first presentation, on “Receptor Signaling in Adipocytes for Energy Expenditure and Metabolic Health Signaling Mechanisms Controlling Adipose Tissue Metabolism,” presenting recent findings obtained in her laboratory in the analysis of receptor signaling in adipocyte. The second speaker of symposium, Professor Sung-Joon Lee, will present “Activation of Olfactory Receptor 544 Reduces Body Fat Accumulation by Inducing Lipolysis in Adipocytes,” which will be an exciting report of an ectopic olfactory receptor in the regulation of energy and lipid metabolism. The third speaker of symposium, Professor Jang Hyun Choi will present “Peroxisome proliferator-activated receptor γ (PPARγ) Signaling and Metabolic Diseases,” covering the recent progress in (PPARγ) signaling, which is a critical regulator of adipose tissue differentiation.
Date & Time : April 21, 09:30-11:00   Venue : Vista 3
Chair
In-kyu Lee (Kyungpook National University School of Medicine, Korea)
Ja Hyun Baik (Korea University, Korea)
Speakers
Receptor Signaling in Adipocytes for Energy Expenditure and Metabolic Health
Sheila Collins (Vanderbilt University, USA)
Activation of Olfactory Receptor 544 Reduces Body Fat Accumulation by Inducing Lipolysis in Adipocytes
Sung-Joon Lee (Korea University, Korea)
PPARγ Signaling and Metabolic Diseases
Jang Hyun Choi (Ulsan National Institute of Science and Technology, Korea)


  
[Symposium: Lipid & Atherosclerosis] : Novel Mediators of Diabetes & Obesity Associated Cardiovascular Diseases
In the Lipid & atherosclerosis session, we are going to discuss a new therapeutic target of cardiovascular disease in relation to metabolic disease together with the three speakers who are actively engaged in basic research on metabolic diseases such as obesity and type 2 diabetes and a new etiology that mediates atherosclerosis. The first speaker, Professor Hye Jin Yoo (Korea University, Korea) is going to present recent research results about the anti-inflammatory effects of Sestrin2, a newly known AMPK modulator, in vascular endothelial cells and myocardial cells, and Professor Chang Hoon Ha (Asan Medical Center, Korea) will give a presentation on the effects of adipokines on vascular homeostasis and angiogenesis. And the last speaker, Professor Noriyuki Ouchi (Nagoya University, Japan) will present the results of the experiment on the protection of ischemic heart disease based on the mechanism of anti-inflammation and anti-apoptosis of the C1q/TNF-related protein known as adiponectin paraglog.
Date & Time : April 21, 09:30-11:00   Venue : Cosmos
Chair
Joong-Yeol Park (ASAN Medical Center, Korea)
Cheol Soo Choi (Gachon University School of Medicine, Korea)
Speakers
Antioxidant Molecule Connecting Metabolic Disorders and Cardiovascular Diseases
Hye Jin Yoo (Korea University Guro Hospital, Korea)
Role of Programmed Cell Death 5 (PDCD5) in Vascular Homeostasis and Angiogenesis
Chang Hoon Ha (ASAN Medical Center, Korea)
Role of the Adiponectin Paralogs C1q/TNF-related Proteins in Cardiovascular Disease
Noriyuki Ouchi (Nagoya University Graduate School of Medicine, Japan)


  
[Plenary Lecture III] : Reproductive Endocrinology
Polycystic ovary syndrome (PCOS) is a very common endocrine disease of women of reproductive age. Recently, the phenotypic and genotypic characteristics in PCOS have been revealed by many researches. However, the exact underlying pathophysiology of PCOS remains unclear and there are still controversies in the diagnosis and treatment of PCOS. In this plenary session, Dr. Yildiz (Hacettepe University, Turkey) will give a lecture about the current and evolving concept of PCOS.
Date & Time : April 21, 11:20-12:00   Venue : Walkerhill Theatre
Chair
Dongsun Kim (Hanyang University Seoul Hospital, Korea)
Speakers
Current and Evolving Concepts in Polycystic Ovary Syndrome
Bulent O Yildiz (Hacettepe University School of Medicine, Turkey)


[Luncheon Symposium] :
Date & Time : April 21, 12:00-12:50   Venue : Vista 1
Chair
Taekeun Oh (Chungbuk National University Hospital, Korea)
Speakers
The Consideration of Individualizing Therapy: Evolving Diabetes Treatment
Sang Youl Rhee (Kyung Hee University School of Medicine, Korea)


[Luncheon Symposium] :
Date & Time : April 21, 12:00-12:50   Venue : Vista 2
Chair
Kyungwan Min (Nowon Eulji Medical Center, Eulji Univerisity, Korea)
Speakers
Not All Statins are the Same : Some Guidance on How to Manage High Risk Patients in Asia
In-Kyung Jeong (Kyung Hee University Hospital at Gangdong, Korea)


[Luncheon Symposium] :
Date & Time : April 21, 12:00-12:50   Venue : Vista 3
Chair
Jung Guk Kim (Kyungpook National University School of Medicine, Korea)
Speakers
The Use of Fixed-dose Combination (FDC) Injectable Therapy in the Management of T2DM
Kathleen Wyne (The Ohio State University, USA)


  
[Meet The Professor] : Reproductive
Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in females and causes reproductive and metabolic problems. Oral contraceptives (OCs) are one of the medical treatment methods in PCOS to ameliorate hyperandrogenism and menstrual irregularities. However, there are concerns about the potential adverse effects of OCs. In this session, Dr. Bulent Yildiz (Hacettepe University, Turkey) will talk about the contraception of women with PCOS.
Date & Time : April 21, 12:50-13:30   Venue : Cosmos
Speakers
Contraception in Women with PCOS: Benefit Versus Risk
Bulent O Yildiz (Hacettepe University School of Medicine, Turkey)


  
[Meet The Professor] : Thyroid
Date & Time : April 21, 12:50-13:30   Venue : Calla
Speakers
Using Genetic Defects to Understand Thyroid Hormone Action
Gregory A. Brent (UCLA, USA)


  
[Special Session] : The World’s Most Influential Scientific Minds in Endocrinology 2017 II
The World’s Most Influential Scientific Minds in Endocrinology 2017 is the session featuring the world-renowned experts in diabetes, bone metabolism, thyroid and neuroendocrinology to review the most influential articles of 2017. Indeed, the session will help you to stay up to date with the latest trends and the most influential studies with interpretation about clinical importance, implication and limitation of studies from the experts in each field.
Date & Time : April 21, 12:50-13:40   Venue : Vista 1
Chair
Sung-Soo Koong (Chungbuk National University Hospital, Korea)
Hyun-Koo Yoon (Cheil General Hospital, Korea)
Speakers
Thyroid
Jae Hoon Chung (Samsung Medical Center, Korea)
Bone
Dong Won Byun (Soon Chun Hyang University Hospital, Seoul, Korea)


  
[Plenary Lecture IV] : Bone
Recently, it is becoming a great issue that the bone is an endocrine organ and regulates various physiological processes. Prof. Gerard Karsenty of Columbia University, who is an expert in this field, has published an outstanding research product related to this topic.
In this plenary lecture, Prof. Karsenty will present his recent work on physiological functions regulated by the musculoskeletal system, such as energy metabolism, male fertility and cognition.
Date & Time : April 21, 14:00-14:40   Venue : Walkerhill Theatre
Chair
Sung-Kil Lim (Yonsei University Graduate School of Medicine, Korea)
Speakers
The Contribution of Bone to Whole Organism Physiology
Gerard Karsenty (Columbia University, USA)


  
[Clinical Update: Bone (K)(T)] : Updates in Osteoporosis Management
In this session, we would like to take time to review the clinical use of the bone turnover markers, the recent Korean Treatment Guidelie of glucocorticoid induced osteoporosis (GIOP) and the diagnosis and treatment of young osteoporosis patients. The first speaker, Yun-Kyung Jeon, Pusan National University Hospital, will share the latest data about the clinical use of the bone turnover marker. The second speaker, So Young Park, Kyung Hee University Hospital, will show new Korea GIOP treatment guideline published by the Korean Society of Bone and Mineral Research. Choi Yong Joon, Ajou University School of Medicine, a third lecturer, will review the pathophysiology and treatment of osteoporosis in young osteoporotic patients.
Date & Time : April 21, 15:00-16:30   Venue : Vista 3
Chair
Chan-Soo Shin (Seoul National University Hospital, Korea)
Jung-Min Koh (ASAN Medical Center , Korea)
Speakers
Clinical Usefulness of Bone Turnover Marker in Osteoporosis
Yun-Kyung Jeon (Pusan National University Hospital, Korea)
GIOP: New Guideline
So Young Park (Kyung Hee University Hospital, Korea)
Management of Osteoporosis in Young Adults
Yong Jun Choi (Ajou University School of Medicine, Korea)


  
[Clinical Update: Thyroid (K)(T)] : Clinical Update in The Management of Thyroid Diseases
This session will provide recent clinical updates in the field of thyroid disease.
Prof. Sun Wook Kim (Sungkyunkwan Univ.) will give a lecture about the effects of long-term medical therapy for the treatment of patients with Graves’ disease. He will also provide detailed information on the preparation and procedures for the radioactive iodine therapy in patients with Graves’ disease.
Prof. Dong Yeob Shin (Yonsei Univ.) will discuss recent trends in TSH suppression therapy for patients with differentiated thyroid cancer (DTC). He will focus on the changes of TSH suppression therapy in recently increased low-risk DTC.
Prof. Hee Kyung Kim (Chonnam Univ.) will give a lecture about practical approach for the management of post-surgical hypoparathyroidism.
Date & Time : April 21, 15:00-16:30   Venue : Vista 2
Chair
Do Joon Park (Korea National Institute of Health / Seoul National University College of Medicine, Korea)
Eun-Sook Kim (Ulsan University Hospital, Korea)
Speakers
Treatment of Graves’ Disease: Long-term Medical Therapy or Radioactive Iodine Therapy
Sun Wook Kim (Samsung Medical Center, Korea)
Recent Trend of TSH Suppression Therapy
Dong Yeob Shin (Yonsei University College of Medicine, Korea)
Management of Post-surgical Hypoparathyroidism
Hee Kyung Kim (Chonnam National University Hwasun Hospital, Korea)


  
[Special Session: Diabetes] : A Deep-dive into Recent Clinical Trial: Recent CV Outcome Trials
Recently, the results of clinical studies for assessing the cardiovascular(CV) safety of diabetic medication have been announced. In the case of DPP-4 inhibitors, the prevention of cardiovascular disease(CVD) was observed in preclinical and some clinical studies. So CV benefits had been expected in the CV safety study but turned out to be not very true; GLP-1 receptor agonists, which are also incretin based therapies, have some preventative effects. However, it is not explained by the class effect because there are drugs in another case. SGLT-2 inhibitors are thought to be class effects in the prevention of CVD, but have somewhat different results. Therefore, this session will provide an opportunity to understand the results of recent clinical studies on the CV safety of these three different types of medicine and to examine clinical implications.
Date & Time : April 21, 15:00-16:30   Venue : Vista 1
Chair
Hyoung-Woo Lee (Yeungnam University Medical Center, Korea)
Moon-Suk Nam (Inha University Hospital, Korea)
Speakers
SAVOR-TIMI, EXAMINE and TECOS ; Why Do DPP-4 Inhibitors Do Not Show Promising CV Effects in CV Outcomes Trials?
Hyuk-Sang Kwon (The Catholic University of Korea Yeouido St. Marys Hospital, Korea)
EMPA-REG and CANVAS : Similar and Dissimilar Results from CV Outcome Trials by SGLT2 Inhibitors
André J Scheen (University of Liege Chu Sart Tilman, Belgium)
CV Outcomes Trials with GLP-1 Receptor Agonists: Similarities and Differences
Young Min Cho (Seoul National University College of Medicine, Korea)


  
[Special-interest Group: Korean Endocrinology Study Group on Aging and Aged (KESA)] : The Effects of Selected Endocrine and Metabolic Perturbations on the Aging Process
This session will review the effects of hormonal and metabolic activity of sarcopenia, thyroid organ and DHEA on the aging process.Sarcopenia is the progressive loss of skeletal muscle that comes with aging. The metabolic effects of sarcopenia also can aggravate aging process. Prof. Kyung-mook Choi will review the relationship between sarcopenia and aging. Thyroid undergo important functional changes during aging. Prof Young-joo Park will present recent findings concerning the alterations in thyroid function during aging, including these which may potentially lead to extended longevity. Finally, DHEA, adrenal steroid hormone that declines with ageing, has been received attention as 'anti-ageing' hormone. However it is not clear that the DHEA has real anti-aging effects. The systemic review of the relationship of DHEA and aging process will be presented by prof. Jeong-hyun Park, the director of the Korean Endocrinology Study Group on Aging and Aged.
Date & Time : April 21, 15:00-16:30   Venue : Cosmos
Chair
Duk Kyu Kim (Dong-A University College of Medicine, Korea)
Hak Chul Jang (Seoul National University Bundang Hospital, Korea)
Speakers
Sarcopenia and Aging
Kyung Mook Choi (Korea University College of Medicine, Korea)
Thyroid and Aging
Young-Joo Park (Seoul National University Hospital, Korea)
DHEA and Aging
Jeong Hyun Park (Inje University College of Medicine, Korea)


    
[Preceptorship Program with KES] : Action for Better Endocrine Care in Asia
The Preceptorial in clinical endocrinology will be conducted at SICEM 2018. SICEM 2018, the official scientific meeting of the Korean endocrinology society is one of the largest international meetings on endocrinology in Asia. This is the first preceptorship that is projected to educate overseas colleagues about advanced management of diverse endocrine diseases.
The faculty that will be conducting this preceptorship includes world-renowned, highly experienced clinicians in adrenal disease, diabetes, pituitary, bone metabolic and thyroid disease. The fellows who are selected to participate in this program will gain up-to-date knowledge and experience in all these areas. Also, there will be many opportunities to have discussions with many members of the faculty.
Hopefully, you will join us for this preceptorship to share friendship, as well as the newest knowledge of endocrinology.
Date & Time : April 22, 09:00-10:30   Venue : Cosmos
Chair
Mia Fojas (University of the Philippines College of Medicine and Philippine General Hospital, Philippines)
Speakers
[Neuroendocrinology] Pituitary Adenoma: Diagnosis and Management
Sang Ouk Chin (Kyung Hee University Hospital School of Medicine, Korea)
[Diabetes] Natural Course of Type 2 Diabetes on the View of Pathogenesis of the Disease
Kyong Soo Park (Seoul National University Hospital , Korea)
[Diabetes] Recent Clinical Updates on Antidiabetic Medications
André J Scheen (University of Liege Chu Sart Tilman, Belgium)


  
[Preceptorship Program with KES] : Action for Better Endocrine Care in Asia
The Preceptorial in clinical endocrinology will be conducted at SICEM 2018. SICEM 2018, the official scientific meeting of the Korean endocrinology society is one of the largest international meetings on endocrinology in Asia. This is the first preceptorship that is projected to educate overseas colleagues about advanced management of diverse endocrine diseases.
The faculty that will be conducting this preceptorship includes world-renowned, highly experienced clinicians in adrenal disease, diabetes, pituitary, bone metabolic and thyroid disease. The fellows who are selected to participate in this program will gain up-to-date knowledge and experience in all these areas. Also, there will be many opportunities to have discussions with many members of the faculty.
Hopefully, you will join us for this preceptorship to share friendship, as well as the newest knowledge of endocrinology.
Date & Time : April 22, 10:50-12:20   Venue : Cosmos
Chair
Dongsun Kim (Hanyang University Seoul Hospital, Korea)
Speakers
[Thyroid] Optimal Management of Low Risk Thyroid Cancers
Won Gu Kim (ASAN Medical Center, Korea)
[Thyroid] Updated Therapy for Advanced Thyroid Cancers
Bo Hyun Kim (Pusan National University College of Medicine, Korea)


  
[Preceptorship Program with KES] : Action for Better Endocrine Care in Asia
The Preceptorial in clinical endocrinology will be conducted at SICEM 2018. SICEM 2018, the official scientific meeting of the Korean endocrinology society is one of the largest international meetings on endocrinology in Asia. This is the first preceptorship that is projected to educate overseas colleagues about advanced management of diverse endocrine diseases.
The faculty that will be conducting this preceptorship includes world-renowned, highly experienced clinicians in adrenal disease, diabetes, pituitary, bone metabolic and thyroid disease. The fellows who are selected to participate in this program will gain up-to-date knowledge and experience in all these areas. Also, there will be many opportunities to have discussions with many members of the faculty.
Hopefully, you will join us for this preceptorship to share friendship, as well as the newest knowledge of endocrinology.
Date & Time : April 22, 13:20-14:20   Venue : Cosmos
Chair
Sompongse Suwanwalaikorn (Chulalongkorn University, Thailand)
Speakers
[Bone] Anti-osteoporotics : Old & New
Bu Kyung Kim (Kosin University College of Medicine, Korea)
[Bone] Osteoporosis Drugs and Dental Issue, MRONJ
Sunghwan Suh (Dong-A University College of Medicine, Korea)


  
[Preceptorship Program with KES] : Action for Better Endocrine Care in Asia
The Preceptorial in clinical endocrinology will be conducted at SICEM 2018. SICEM 2018, the official scientific meeting of the Korean endocrinology society is one of the largest international meetings on endocrinology in Asia. This is the first preceptorship that is projected to educate overseas colleagues about advanced management of diverse endocrine diseases.
The faculty that will be conducting this preceptorship includes world-renowned, highly experienced clinicians in adrenal disease, diabetes, pituitary, bone metabolic and thyroid disease. The fellows who are selected to participate in this program will gain up-to-date knowledge and experience in all these areas. Also, there will be many opportunities to have discussions with many members of the faculty.
Hopefully, you will join us for this preceptorship to share friendship, as well as the newest knowledge of endocrinology.
Date & Time : April 22, 14:40-16:00   Venue : Cosmos
Chair
Sin Gon Kim (Korea University Anam Hospital, Korea)
Speakers
[Adrenal] Recent Advance in the Management of Adrenal Insufficiency
Hye Soon Kim (Keimyung University Dongsan Hospital, Korea)
[Adrenal] Approach to Adrenal Incidentaloma - What to Do?
Ohk-Hyun Ryu (Hallym University College of Medicine, Korea)


   



SICEM
History of KES & EnM
Past SICEMs
Related Meetings
SICEM 2018
Welcome Message
Overview
Venue
Organizing Committee
Scientific Program Committee
Program
Program at a Glance
Scientific Program
New for SICEM 2018
Invited Speakers
Social Program
Call for Abstracts
Submission Guidelines
Travel Grant & Awards
Presenter's Guidelines
Participation
Registration
Accommodation

General Information
Seoul, Korea
Visa Information
Transportation
Useful Information

NEWS & GALLERY
What's New
Photo Gallery
Download





Business License Number: 106-82-31113 | Dongsun Kim
101-2503, 109, Mapo-daero, Mapo-gu, Seoul 04146, Korea
Email: endo@endocrinology.or.kr
Copyright ⓒ SICEM 2018. All Rights Reserved.
  Secretariat of SICEM 2018
INTERCOM Convention Services, Inc
8~10 FL Samick Lavied'or Bldg., Teheran-ro, Gangnam-gu, Seoul, Korea, 06221
T: +82-2-3452-1444 F: +82-2-6254-8049
Email. sicem@intercom.co.kr | office@sicem.kr